3. Metabolic Disease 1: Animal Models Flashcards
How does T1D lead to hyperglycaemia?
- Pancreas makes little/no insulin due to immune system attacking B cells
- Little insulin in bloodstream means glucose cannot enter cells and therefore accumulates in bloodstream
- Leads to hyperglycaemia
How does T2D lead to hyperglycaemia?
- Pancreas make insulin which enters bloodstream
- Due to insulin resistance of peripheral cells glucose cannot enter and therefore accumulates in bloodstream
- Leads to hyperglycaemia
How can T1D and T2D be similar?
Both T1D and late-stage T2D show B cell depletion despite early mechanistic differences
Describe the natural history of T2D.
- Before metabolic defects that lead to T2D, fasting and post-meal glucose levels are similar and constant
- As T2D develops, insulin resistance increases over time, leading to compensatory increases in insulin secretion t prevent blood glucose levels rising
- Eventually insulin resistance peaks and stabilises whilst insulin secretion continues to increase
- At crisis point, B cells become depleted/dysfunctional and so insulin secretion cannot match insulin resistance leading to hyperglycaemia
What is thought to be a major risk for T2D?
There is a strong correlation between obesity and T2D
Why is it unclear how obesity leads to T2D?
So many tissues are involved in glucose homeostasis and they all interact with one another therefore hard to understand cause vs consequence
What is the relationship between obesity, insulin resistance and dyslipidemia?
- Central obesity is associated with an increase in free fatty acids (FFA) and insulin resistance (unclear whether increased FFA causes insulin resistance or vice versa)
- These 2 effects stimulate increased hepatic apolipoprotein B and hepatic lipase activity (catalyse removal of lipids from HDLs)
- This leads to hypertriglyceridemia, increased small, dense LDLs and decreased HDLs
- These abnormal lipid patterns increase risk of developing plaques in the CV system and therefore increases the risk of co-morbidity
What is co-morbidity?
Having more than 1 recognised disease
What is the cause of hyperglycaemia in T2D?
3 major body metabolic defects:
- Increased hepatic glucose production
- Decreased pancreatic insulin secretion
- Increased peripheral insulin resistance
How have animal models been used to study how obesity can trigger T2D?
What is the problem with this study?
- Obesity characterised by accumulation of excess fat in ectopic sites (liver and skeletal muscle) instead of accumulation in adipocytes - this is associated with insulin resistance and T2D
- Hypothesis: Adipocytes are critical to prevent T2D
- Genetically-engineered mice lacking adipocytes show hyperphagia, insulin resistance and T2D
- However, due to lack of adipocytes these mice are leptin-deficient - leptin’s primary effects are on the brain therefore primary trigger may be brain dysfunction
How can transgenic reporter lines be used in the study of T2D?
Allow us to analyse specific tissues involved in glucose homeostasis in real time and space:
- In healthy animals
- In animals with genetic mutation (to study impact of human genetic variation)
- In animals subjected to different environmental conditions (e.g. high fat diet)
What is a future idea for a study to understand triggers in T2D?
- Cross 3 reporter lines to make fish that reports pancreas, liver and adipose tissue
- Feed fish high fat diet and observe which tissue is affected first
What is a reporter line used to specifically visualise B cells?
Tg(ins:Kaede)
Describe a technique for analysing proliferation.
EDU labelling
- EDU is an analog of Thymidine that has been modified to allow visualisation of proliferation
- Incubate cells with EDU
- EDU is incorporated into DNA during active DNA synthesis that occurs prior to cell division
- Incorporated EDU in DNA can then be detected with click chemistry procedure which makes nucleus fluoresce
What is the current treatment for diabetes?
What is wrong with this?
What is a potential new treatment?
What must be known for this to be possible?
- Insulin injections
- Does not increase life expectancy or decrease morbidity
- Restore B cell numbers
- Need to know what controls B cell number in development and regeneration